Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1575127
PUBLISHER: Grand View Research | PRODUCT CODE: 1575127
In Vitro Diagnostics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Instruments, Software & Services), By Service, By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
In Vitro Diagnostics Contract Manufacturing Market Growth & Trends:
The global in vitro diagnostics contract manufacturing market size is expected to reach USD 37.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.04% over the forecast period.
The market is anticipated to witness lucrative growth potential owing to rising demand for diagnostic devices, an upsurge in point-of-care diagnostics, advancements in molecular testing, and the increasing prevalence of chronic diseases. Moreover, the growing need for cost-effective manufacturing, technological innovation, and stringent regulatory compliance for diagnostics is expected to drive the market revenue stream. Thus, the increasing trend for outsourcing manufacturing services to CMOs and CDMOs to access specialized expertise, streamline production, and accelerate time-to-market among healthcare companies is boosting overall market growth.
The high cost of in-house IVD manufacturing is a significant driver propelling the market growth. The need for high capital investment in infrastructure, specialized equipment, regulatory compliance, and skilled workforce to develop and scale up IVD production will accelerate market growth. These overhead costs strain resources, reducing profitability and flexibility among several small and medium-scale organizations. Thus, by outsourcing manufacturing services to CMOs & CDMOs, companies can lower manufacturing costs and gain access to innovative technologies exclusive of the need for internal capital investment. Moreover, outsourcing allows faster market entry, enhanced scalability, and better resource optimization and offers a competitive edge in the IVD market.
Furthermore, continuous technological advancements are among the major factors accelerating the market demand, specifically for diagnostic devices and testing solutions. Innovations such as molecular diagnostics, next-generation sequencing (NGS), and automation have enhanced the accuracy, speed, and efficiency of IVD manufacturing processes. These advancements assist manufacturers to meet the increasing demand for personalized medicine, point-of-care diagnostics, and faster disease detection methods. Moreover, the integration of AI-driven technologies and data analytics optimizes production workflows and quality assurance processes, enhancing precision and compliance with regulatory standards. Furthermore, numerous healthcare companies are involved in collaboration with contract manufacturers to access such novel technologies to accelerate time-to-market, reduce operational costs, and enhance product scalability. Thus, the integration of advanced technologies by service providers is estimated to drive market growth in the forthcoming years.
In Vitro Diagnostics Contract Manufacturing Market Report Highlights:
- Based on product, the reagents & consumables segment dominated the market with a revenue share of 69.34% in 2023. The segment growth is attributed to increasing demand for rapid diagnostic solutions and personalized medicine. Moreover, increasing preference for molecular diagnostics and point-of-care testing are boosting the need for specialized reagents. In addition, continuous advances in automation and next-generation sequencing (NGS) are further bolstering the demand for high-quality consumables.
- Based on service, the manufacturing services segment held the largest share in 2023. The increasing demand for rapid, high-quality diagnostics and personalized healthcare solutions spurs the demand for scale-up production, thereby expanding the contract services market. In addition, the need for cost-effective production and compliance with stringent regulatory standards drives healthcare companies to outsource manufacturing to meet the growing needs of the IVD market.
- Based on technology, the immunoassay segment accounted for the largest revenue share in 2023. This large revenue share is owing to the rising demand for accurate and rapid diagnostic tests. Moreover, the increasing prevalence of chronic diseases and a growing emphasis on personalized medicine is anticipated to drive segmental growth. In addition, innovations in biomarker discovery and the expansion of point-of-care diagnostics are propelling market expansion.
- Based on end use, the medical device companies segment accounted for the largest revenue share in 2023.Growing demand for advanced, customizable diagnostic solutions and the integration of digital technologies for enhanced accuracy are key factors accelerating segment growth. Moreover, stringent quality standards and the integration of innovative technologies by service providers are major factors accelerating collaboration and partnerships by medical device companies with contract manufacturers that offer innovative capabilities and flexible solutions to meet growing market needs.
- North America dominated the market with a share of 41.91% in 2023. The increasing prevalence of chronic diseases and the demand for advanced diagnostic solutions in the North American region are propelling market expansion. In addition, the rising need for cost-effective manufacturing solutions is leading healthcare companies to outsource IVD production. Regulatory support and innovation in diagnostic technologies further drive market momentum, creating opportunities for growth and collaboration within the contract manufacturing sector.
Product Code: GVR-4-68040-462-6
Table of Contents
Chapter 1. Research Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Regional Scope
- 1.1.2. Estimates And Forecast Timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information Or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.7.2. Parent Market Analysis
- 1.8. List Of Secondary Sources
- 1.9. List Of Abbreviations
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. In Vitro Diagnostics Contract Manufacturing Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Technology Landscape
- 3.4. Industry Ecosystem Analysis
- 3.5. Industry Analysis Tools
- 3.5.1. Porter's Five Forces Analysis
- 3.5.2. PESTEL Analysis
- 3.5.3. COVID-19 Impact Analysis
Chapter 4. In Vitro Diagnostics (Contract Manufacturing Market: Phases Estimates & Trend Analysis
- 4.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Segment Dashboard
- 4.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Product: Movement Analysis
- 4.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Product, 2018 - 2030 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments Market, 2018 to 2030 (USD Million)
- 4.5. Reagents & Consumables
- 4.5.1. Reagents & Consumables Market, 2018 to 2030 (USD Million)
- 4.6. Software & Services
- 4.6.1. Software & Services Market, 2018 to 2030 (USD Million)
Chapter 5. In Vitro Diagnostics Contract Manufacturing Market: Service Estimates & Trend Analysis
- 5.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Segment Dashboard
- 5.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Service: Movement Analysis
- 5.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
- 5.4. Manufacturing Services
- 5.4.1. Manufacturing Services Market, 2018 to 2030 (USD Million)
- 5.5. Assay Development Services
- 5.5.1. Assay Development Services Market, 2018 to 2030 (USD Million)
- 5.6. Other Services
- 5.6.1. Other Services Market, 2018 to 2030 (USD Million)
Chapter 6. In Vitro Diagnostics Contract Manufacturing Market: Technology Estimates & Trend Analysis
- 6.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Segment Dashboard
- 6.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By Technology: Movement Analysis
- 6.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By Technology, 2018-2030
- 6.4. Immunoassays
- 6.4.1. Immunoassays Market, 2018 to 2030 (USD Million)
- 6.5. Clinical Chemistry
- 6.5.1. Clinical Chemistry Market, 2018 to 2030 (USD Million)
- 6.6. Molecular Diagnostics
- 6.6.1. Molecular Diagnostics Market, 2018 to 2030 (USD Million)
- 6.7. Hematology
- 6.7.1. Hematology Market, 2018 to 2030 (USD Million)
- 6.8. Microbiology
- 6.8.1. Microbiology Market, 2018 to 2030 (USD Million)
- 6.9. Coagulation
- 6.9.1. Coagulation Market, 2018 to 2030 (USD Million)
- 6.10. Others
- 6.10.1. Others Market, 2018 to 2030 (USD Million)
Chapter 7. In Vitro Diagnostics Contract Manufacturing Market: End Use Estimates & Trend Analysis
- 7.1. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Segment Dashboard
- 7.2. In Vitro Diagnostics (IVD) Contract Manufacturing Market, By End Use: Movement Analysis
- 7.3. In Vitro Diagnostics (IVD) Contract Manufacturing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
- 7.4. Medical Device Companies
- 7.4.1. Medical Device Companies Market, 2018 to 2030 (USD Million)
- 7.5. Academic & Research Institutions
- 7.5.1. Academic & Research Institutions Market, 2018 to 2030 (USD Million)
- 7.6. Others
- 7.6.1. Others Market, 2018 to 2030 (USD Million)
Chapter 8. In Vitro Diagnostics Contract Manufacturing Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2023 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. North America
- 8.4.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
- 8.4.2. U.S.
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Europe
- 8.5.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
- 8.5.2. UK
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Framework
- 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Framework
- 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Sweden
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Framework
- 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Denmark
- 8.5.8.1. Key Country Dynamics
- 8.5.8.2. Competitive Scenario
- 8.5.8.3. Regulatory Framework
- 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Norway
- 8.5.9.1. Key Country Dynamics
- 8.5.9.2. Competitive Scenario
- 8.5.9.3. Regulatory Framework
- 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Asia Pacific
- 8.6.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
- 8.6.2. Japan
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. Thailand
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. South Korea
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competitive Scenario
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Australia
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Competitive Scenario
- 8.6.7.3. Regulatory Framework
- 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Latin America
- 8.7.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
- 8.7.2. Brazil
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8. MEA
- 8.8.1. Market Estimates and Forecast, 2018-2030 (Revenue, USD Million)
- 8.8.2. South Africa
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Competitive Scenario
- 8.8.4.3. Regulatory Framework
- 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Competitive Scenario
- 8.8.5.3. Regulatory Framework
- 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.1.1. Market Leaders
- 9.1.2. Emerging Players
- 9.2. Company Market Share/Assessment Analysis, 2023
- 9.3. Service Heat Map Analysis, 2023
- 9.4. Company Profiles
- 9.4.1. Jabil Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Service Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Sanmina Corporation
- 9.4.2.1. Company Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Service Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. TE Connectivity
- 9.4.3.1. Company Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Service Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Celestica Inc.
- 9.4.4.1. Company Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Service Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Savyon Diagnostics
- 9.4.5.1. Company Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Service Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. West Pharmaceutical Services, Inc.
- 9.4.6.1. Company Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Service Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. Thermo Fisher Scientific
- 9.4.7.1. Company Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Service Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. KMC Systems
- 9.4.8.1. Company Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Service Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Cenogenics Corporation
- 9.4.9.1. Company Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Service Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Novo Biomedical
- 9.4.10.1. Company Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Service Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.11. Cone Bioproducts
- 9.4.11.1. Company Overview
- 9.4.11.2. Financial Performance
- 9.4.11.3. Service Benchmarking
- 9.4.11.4. Strategic Initiatives
- 9.4.12. Invetech
- 9.4.12.1. Company Overview
- 9.4.12.2. Financial Performance
- 9.4.12.3. Service Benchmarking
- 9.4.12.4. Strategic Initiatives
- 9.4.13. AVIOQ Inc.
- 9.4.13.1. Company Overview
- 9.4.13.2. Financial Performance
- 9.4.13.3. Service Benchmarking
- 9.4.13.4. Strategic Initiatives
- 9.4.14. Meridian Bioscience Inc.
- 9.4.14.1. Company Overview
- 9.4.14.2. Financial Performance
- 9.4.14.3. Service Benchmarking
- 9.4.14.4. Strategic Initiatives
- 9.4.15. Nemera
- 9.4.15.1. Company Overview
- 9.4.15.2. Financial Performance
- 9.4.15.3. Service Benchmarking
- 9.4.15.4. Strategic Initiatives
- 9.4.1. Jabil Inc.
Product Code: GVR-4-68040-462-6
List of Tables
- Table. 1 Market segmentation
- Table. 2 Market research process
- Table. 3 Information procurement
- Table. 4 Primary research pattern
- Table. 5 Market research approaches
- Table. 6 Value chain-based sizing & forecasting
- Table. 7 QFD modelling for market share assessment
- Table. 8 Market formulation & validation
- Table. 9 In Vitro Diagnostics (IVD) contract manufacturing market revenue, 2018 - 2030 (USD Million)
- Table. 10 In Vitro Diagnostics (IVD) contract manufacturing market snapshot
- Table. 11 In Vitro Diagnostics (IVD) contract manufacturing market driver impact
- Table. 12 In Vitro Diagnostics (IVD) contract manufacturing market restraint impact
- Table. 13 In Vitro Diagnostics (IVD) contract manufacturing sector key takeaways (USD Million)
- Table. 14 In Vitro Diagnostics (IVD) contract manufacturing Market: Product movement analysis
- Table. 15 Instruments market, 2018 - 2030 (USD Million)
- Table. 16 Reagents & consumables market, 2018 - 2030 (USD Million)
- Table. 17 Software & services market, 2018 - 2030 (USD Million)
- Table. 18 In Vitro Diagnostics (IVD) contract manufacturing market service key takeaways (USD Million)
- Table. 19 In Vitro Diagnostics (IVD) contract manufacturing market: service movement analysis
- Table. 20 Manufacturing services market, 2018 - 2030 (USD Million)
- Table. 21 Assay development services market, 2018 - 2030 (USD Million)
- Table. 22 Other services market, 2018 - 2030 (USD Million)
- Table. 23 In Vitro Diagnostics (IVD) contract manufacturing market technology key takeaways (USD Million)
- Table. 24 In Vitro Diagnostics (IVD) contract manufacturing market: technology movement analysis
- Table. 25 Immunoassays market, 2018 - 2030 (USD Million)
- Table. 26 Clinical chemistry market, 2018 - 2030 (USD Million)
- Table. 27 Molecular diagnostics market, 2018 - 2030 (USD Million)
- Table. 28 Hematology market, 2018 - 2030 (USD Million)
- Table. 29 Microbiology market, 2018 - 2030 (USD Million)
- Table. 30 Coagulation market, 2018 - 2030 (USD Million)
- Table. 31 Others market, 2018 - 2030 (USD Million)
- Table. 32 In Vitro Diagnostics (IVD) contract manufacturing market end use key takeaways (USD Million)
- Table. 33 In Vitro Diagnostics (IVD) contract manufacturing market: end use movement analysis
- Table. 34 Medical device companies' market, 2018 - 2030 (USD Million)
- Table. 35 Academic & research institutions market, 2018 - 2030 (USD Million)
- Table. 36 Others market, 2018 - 2030 (USD Million)
- Table. 37 Regional marketplace: Key takeaways
- Table. 38 Regional outlook, 2023 & 2030
- Table. 39 North America In Vitro Diagnostics (IVD) contract manufacturing Market, 2018 - 2030 (USD Million)
- Table. 40 U.S. In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 41 Canada In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 42 Mexico In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 43 Europe In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 44 UK In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 45 Germany In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 46 France In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 47 Italy In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 48 Spain companion animal Health market, 2018 - 2030 (USD Million)
- Table. 49 Sweden In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 50 Denmark In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 51 Norway In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 52 Asia Pacific In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 53 Japan In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 54 China In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 55 India In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 56 Thailand In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 57 South Korea In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 58 Australia In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 59 Latin America In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 60 Brazil In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 61 Argentina In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 62 Middle East & Africa In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 63 South Africa In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 64 Saudi Arabia In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 65 UAE In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 66 Kuwait In Vitro Diagnostics (IVD) contract manufacturing market, 2018 - 2030 (USD Million)
- Table. 67 Market participant categorization
List of Figures
- Fig. 1 List of Tables
- Fig. 2 List of Secondary Sources
- Fig. 3 List of Abbreviations
- Fig. 4 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 5 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 6 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 7 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 8 Global In Vitro Diagnostics (IVD) Contract Manufacturing, by Region, 2018 - 2030 (USD Million)
- Fig. 9 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
- Fig. 10 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 11 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 12 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 13 North America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 14 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 15 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 16 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 17 U.S. In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 18 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 19 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 20 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 21 Canada In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 22 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 23 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 24 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 25 Mexico In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 26 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
- Fig. 27 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 28 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 29 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 30 Europe In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 31 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 32 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 33 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 34 Germany In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 35 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 36 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 37 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 38 UK In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 39 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 40 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 41 France In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 42 France In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 43 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 44 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 45 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 46 Italy In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 47 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 48 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 49 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 50 Spain In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 51 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 52 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 53 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 54 Denmark In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 55 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 56 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 57 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 58 Sweden In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 59 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 60 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 61 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 62 Norway In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 63 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
- Fig. 64 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 65 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 66 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 67 Asia Pacific In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 68 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 69 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 70 China In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 71 China In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 72 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 73 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 74 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 75 Japan In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 76 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 77 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 78 India In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 79 India In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 80 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 81 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 82 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 83 South Korea In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 84 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 85 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 86 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 87 Australia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 88 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 89 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 90 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 91 Thailand In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 92 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
- Fig. 93 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 94 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 95 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 96 Latin America In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 97 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 98 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 99 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 100 Brazil In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 101 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 102 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 103 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 104 Argentina In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 105 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Country, 2018 - 2030 (USD Million)
- Fig. 106 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 107 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 108 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 109 Middle East & Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 110 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 111 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 112 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 113 South Africa In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 114 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 115 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 116 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 117 Saudi Arabia In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 118 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 119 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 120 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 121 UAE In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
- Fig. 122 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Product, 2018 - 2030 (USD Million)
- Fig. 123 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Service, 2018 - 2030 (USD Million)
- Fig. 124 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by Technology, 2018 - 2030 (USD Million)
- Fig. 125 Kuwait In Vitro Diagnostics (IVD) Contract Manufacturing, by End Use, 2018 - 2030 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.